Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Albus

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Psychiatrische Praxis|November 1, 1995
[The problem of drug compliance in schizophrenic patients]M Albus
Pharmacopsychiatry|May 9, 2012
Clinical courses of schizophreniaM Albus
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1988
CholecystokininM Albus
Der Nervenarzt|November 1, 1990
[Psychophysiology of anxiety diseases]M Albus
MMW Fortschritte Der Medizin|July 4, 2001
[Established and atypical neuroleptics. What the family physician should know]M Albus
Monographien Aus Dem Gesamtgebiete Der Psychiatrie|January 1, 1991
[The biological correlates of anxiety in psychiatric diseases]M Albus
Psychopathology|January 1, 1992
Differentiation of DSM-III-R anxiety disorders by severity of illness and symptom onset sequencesG Scheibe, M Albus
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1994
Prospective follow-up study lasting 2 years in patients with panic disorder with and without depressive disordersG Scheibe, M Albus
The American Journal of Psychiatry|October 13, 1999
Neuropsychological functions in patients with schizophreniaM Albus, W Hubmann
Psychopathology|January 1, 1997
Predictors and outcome in panic disorder: a 2-year prospective follow-up studyG Scheibe, M Albus
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Psychiatrische Praxis|November 1, 1995
[The problem of drug compliance in schizophrenic patients]M Albus
Pharmacopsychiatry|May 9, 2012
Clinical courses of schizophreniaM Albus
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1988
CholecystokininM Albus
Der Nervenarzt|November 1, 1990
[Psychophysiology of anxiety diseases]M Albus
MMW Fortschritte Der Medizin|July 4, 2001
[Established and atypical neuroleptics. What the family physician should know]M Albus
Monographien Aus Dem Gesamtgebiete Der Psychiatrie|January 1, 1991
[The biological correlates of anxiety in psychiatric diseases]M Albus
Psychopathology|January 1, 1992
Differentiation of DSM-III-R anxiety disorders by severity of illness and symptom onset sequencesG Scheibe, M Albus
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1994
Prospective follow-up study lasting 2 years in patients with panic disorder with and without depressive disordersG Scheibe, M Albus
The American Journal of Psychiatry|October 13, 1999
Neuropsychological functions in patients with schizophreniaM Albus, W Hubmann
Psychopathology|January 1, 1997
Predictors and outcome in panic disorder: a 2-year prospective follow-up studyG Scheibe, M Albus
Pageof 12